Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th June 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EMA committee recommends first stem cell-based veterinary medicine
Arti-cell Forte is recommended for use in horses with mild to moderate lameness related to joint inflammation.
Arti-cell Forte indicated for use in horses with lameness

The first stem cell-based veterinary medicine has been recommended for marketing authorisation in the European Union by The European Medicines Agency's (EMA) Committee for Medicinal Products (CVMP).

Arti-cell Forte is recommended for use in horses with mild to moderate lameness related to joint inflammation. It is available as a suspension for injection and is given as a single injection into the affected joint.

In a press release, the EMA said the stem cells in the medicine are treated so they develop towards cartilage cells. This can then help to repair damaged cartilage in the joint.

‘In a field study conducted in horses with lameness of the fetlock joint, Arti-Cell Forte showed a statistically significant improvement in the horses treated with the medicine compared with a placebo control group six weeks after treatment,’ the EMA writes. ‘The positive effect of treatment was sustained over one year.’

Common side effects of the medicine reported in the study were mild increase in lameness and injection site reactions in the week following treatment.

The CVMP’s recommendation will now be passed on to the European Commission for a decision on an EU-wide marketing authorisation. 

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.